We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

AIDIAN

Aidian, formerly Orion Diagnostica, is a Finnish-based IVD company with almost 50 years of experience in developing a... read more Featured Products: More products

Download Mobile App





Orion Diagnostica Showcases Range of Products in Anaheim

By LabMedica International staff writers
Posted on 05 Aug 2019
Orion Diagnostica (Espoo, Finland) showcased its FDA-cleared QuikRead go CRP along with other QuikRead go products at the 71st AACC Annual Scientific Meeting & Clinical Lab Expo held in Anaheim, California, USA, from August 6-8.

Orion Diagnostica specializes in accurate and affordable clinical diagnostic and hygiene monitoring tests. More...
It focuses on point-of-care diagnostic tools that enable healthcare professionals to detect diseases more quickly, make evidence-based diagnoses and treatment decisions, and follow up on treatment outcomes. Orion Diagnostica’s QuikRead go CRP test is an immunoturbidimetric assay for the in vitro quantitative determination of C-reactive protein (CRP) in K2-EDTA and lithium heparin whole blood, K2-EDTA and lithium heparin plasma, and in serum samples.

The test is carried out by means of the company’s QuikRead go instrument, a compact, automatic system that can be connected to HIS/LIS systems. The QuikRead go makes it easy to add patient and/or operator identification information together with the result which is automatically stored in the instrument’s internal memory. Its intuitive user interface enables a variety of settings to be personalized and the instrument can be easily combined with accessories, such as a barcode reader and a printer.

At AACC 2019, Orion Diagnostica also showcased its Hygicult and Easicult products for hygiene monitoring. Orion Diagnostica’s Easicult products are easy to use culture tests intended for monitoring microbial contaminations in industrial fluids. Using Easicult does not require any microbiological expertise, advance preparation or equipment and the slides can easily be used on-site. The test slides can be used as convenient transport media if further analysis of the samples is needed. Similarly, the company’s Hygicult product line comprises of a selection of dipslide culture tests, which are designed for reliable, economic and timesaving on-site microbial detection, especially on surfaces. The slides can also be used as convenient transport media for cultured samples.


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
New
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
New
Neurofilament Light Chain Assay
Lumipulse G NfL Blood
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: iStock

Prehospital Blood Test Could Reduce Emergency Transfers for Chest Pain

Chest pain leads to ambulance transport to an emergency department for about 95% of patients, although only a minority have a serious cardiac condition. Troponin testing helps assess heart muscle damage,... Read more

Molecular Diagnostics

view channel
Image Credit: 123RF

Genetic Testing Program Helps Uncover Inherited Risk in Pediatric Cancer

Inherited cancer risk can affect children, adolescents and young adults, but it may not always be apparent from tumor type or family history alone. Some cancer syndromes require specialized expertise and... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Microbiology

view channel
Image: Each PhAST instrument supports random-access processing of up to four samples simultaneously, delivering a throughput of up to 12 samples per eight-hour shift. (Photo courtesy of PhAST)

FDA Clears Rapid Phenotypic Antimicrobial Susceptibility System for Positive Blood Cultures

Bloodstream infections require prompt treatment, but antimicrobial susceptibility results often lag behind a positive blood culture. Conventional testing can take another 24 to 48 hours after a culture... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.